Imperial College London | GenomeWeb

Imperial College London

The DNA foundries have been funded through an £18 million ($23.5 million) investment from the BBSRC and should all be fully operational by next year.

Using absolute and relative gene expression analyses, researchers identified expression patterns associated with preeclampsia in dozens of placental tissue samples.

Researchers examined virulence, resistance, and transmission patterns in genome sequence data for more than 300 invasive Staphylococcus aureus isolates from Europe.

They will use the funds to develop software tools for designing and testing site-specific CRISPR systems that target drug resistance mechanisms in cancer cells.

Re-sequencing of the Schistosoma mansoni genome provides insight into the parasite's population history.

A University College London-led team has found that microdeletions and microduplications cannot be reliably detected by non-invasive prenatal testing.

Data from four cohorts suggest cytosine sites in the AHRR and F2RL3 genes are hypomethylated in pre-diagnostic blood samples from individuals at risk of lung cancer.

Researchers detected a truncating mutation in the carboxypeptidase E gene in members of a Sudanese family affected by extreme obesity, glucose metabolism problems, and other symptoms.

Through unbiased and targeted metabolite testing on urine samples from thousands of individuals in the US and the UK, researchers have narrowed in on urine compounds that coincide with body mass index.

The method could speed up work on synthetic gene circuits and help make gene cloning easier throughout molecular biology.

Pages

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.